Research on the Elucidation of the Prognostic Factor and Mechanism of Drug Resistance in Gastric Cancer Patients who Receive Systemic Chemotherapy.
Not Applicable
Recruiting
- Conditions
- Gastric cancer patients with primary lesion.
- Registration Number
- JPRN-UMIN000009564
- Lead Sponsor
- Department of Gastrointestinal Oncology, National Cancer Center Hospital in Japan
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
Not provided
Exclusion Criteria
1.Patients who need continuous anti- coaglant therapy (impossible to stop anti-coaglant therapy). 2.Patients who are considered to be ineligible by referring physician.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method